Urinary polyamines in cancer patients.
D001932:Brain Neoplasms / Q000601:surgery / Q000652:urine; D002624:Chemistry, Clinical; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000652:urine; D006801:Humans; D007945:Leukemia, Lymphoid / Q000652:urine; D007951:Leukemia, Myeloid / Q000652:urine; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000652:urine; D016403:Lymphoma, Large B-Cell, Diffuse / Q000652:urine; D008228:Lymphoma, Non-Hodgkin / Q000652:urine; D009101:Multiple Myeloma / Q000652:urine; D009369:Neoplasms / Q000652:urine*; D010051:Ovarian Neoplasms / Q000601:surgery / Q000652:urine; D011073:Polyamines / Q000652:urine*; D011247:Pregnancy; D012075:Remission, Spontaneous; D013095:Spermidine / Q000652:urine; D013096:Spermine / Q000652:urine*; D013724:Teratoma / Q000601:surgery / Q000652:urine
D011073:Polyamines; D013096:Spermine; D013095:Spermidine; D003630:Daunorubicin